Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2871-2880

  Johnson, Teresa R ^a   Johnson, Joyce E ^b   Roberts, Sharon R ^c   Wertz, Gail W ^d   Parker, Robert A ^e   Graham, Barney S ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c AUBURN UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; THROMBOSPONDIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EOSINOPHILIA; IMMUNE RESPONSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0031925039     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2871-2880.1998     Document Type: Article

References (70)

1. Alwan, W., W. Kozlowska, and P. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179: 81-89.
2. Alwan W., and P. Openshaw. 1993. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11:431-437
3. Alwan, W., F. Record, and P. Openshaw. 1992. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus: comparison with the effects of CD8+ T cells. Clin. Exp. Immunol. 88:527-536.
4. Alwan, W., F. Record, and P. Openshaw. 1993. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Immunol. 150:5211-5218.
5. Anderson, L., and C. Heilman. 1995. Protective and disease-enhancing immune response to respiratory syncytial virus. J. Infect. Dis 171:1-7.
6. Ball, L., K. Young, K. Anderson, P. Collins, and G. Wertz. 1986. Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proc. Natl. Acad. Sci. USA 83:246-250.
7. Bangham, C., M. Cannon, D. Karzon, and B. Askonas. 1985. Cytotoxic T-cell response to respiratory syncytial virus in mice. J. Virol. 56:55-59.
8. Bangham, C., P. Openshaw, A. Ball, A. King, G. Wertz, and B. Askonas. 1986. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J. Immunol. 137:3973-3977.
9. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
10. Connors, M., P. Collins, C. Firestone, A. Sotnikov, A. Waitze, A. Davis, P. Hung, R. Chanock, and B. Murphy. 1992. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia-RSV recombinants or RSV. Vaccine 10:475-484.
11. Conradt, P., and S. Kaufmann. 1995. Impact of antigen-presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect. Immun. 63:2079-2081.
12. Constant, S., C. Pfeiffer, A. Woodard, T. Pasqualini, and K. Bottomly. 1995. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1591-1596.
13. Corry, D., S. Reiner, P. Linsley, and R. Locksley. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142-4148.
14. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418.
15. Gazzinelli, R. T., S. Baia, R. Stevens, M. Baseler, L. Wahl, J. Kovacs, and A. Sher. 1995. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J. Immunol. 155:1565-1574.
16. Gazzinelli, R. T., M. Makino, S. K. Chattopadhyay, C. M. Snapper, A. Sher, A. W. Hugin, and H. C. Morse. 1992. CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148:182-188.
17. Graham, B. S. 1996. Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol. 4:290-294.
18. Graham, B. 1995. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am. J. Respir. Crit. Care Med. 152:563-566.
19. Graham, B., G. Henderson, Y. Tang, X. Lu, K. Neuzil, and D. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
20. Graham, B., M. Perkins, P. Wright, and D. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162.
21. Griffin, D. E., and B. J. Ward. 1993. Differential CD4 T cell activation in measles. J. Infect. Dis. 168:275-281.
22. Gruber, C., and S. Levine. 1983. Respiratory syncytial virus polypeptides. III. The envelope-associated proteins. J. Gen. Virol. 64:825-832.
23. Hall, C., E. Walsh, C. Long, and K. Schnabel. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163: 693-698.
24. Hall, W., and S. Martin. 1973. Purification and characterization of measles virus. J. Gen. Virol. 19:175-188.
25. Hancock, G., D. Speelman, K. Heers, E. Bortell, J. Smith, and C. Cosco. 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70:7783-7791.
26. Hendricks, D., K. Baradaran, K. McIntosh, and J. Patterson. 1987. Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J. Gen. Virol. 68:1705-1714.
27. Hendricks, D., K. McIntosh, and J. Patterson. 1988. Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J. Virol. 62:2228-2233.
28. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennicnk, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415.
29. Hosken, N. A., K. Shibuya, A. W. Heath, K. M. Murphy, and A. O'Garra. 1995. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:1579-1584.
30. Hu, F. Q., C. A. Smith, and D. J. Pickup. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343-356.
31. Johnson, P., M. Spriggs, R. Olmstead, and P. Collins. 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA 84:5625-5629.
32. Kapikian, A., R. Mitchell, R. Chanock, R. Shvedoff, and C. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
33. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228-231.
34. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, and R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
35. Kim, H., S. Leikin, J. Arrobio, C. Brandt, R. Chanock, and R. Parrott. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 10:75-78.
36. Kita, H., S. Horie, and G. J. Gleich. 1996. Extracellular matrix proteins attenuate activation and degranulalion of stimulated eosinophils. J. Immunol. 156:1174-1181.
37. Kurup, V. P., B. W. Seymour, H. Choi, and R. L. Coffman. 1994. Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice. J. Allergy Clin. Immunol. 93:1013-1020.
38. Lambert, D. 1988. Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 16:458-466.
39. Langedijk, J., W. Schaaper, R. Meloen, and J. van Oirschot. 1996. Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J. Gen. Virol. 77:1249-1257.
40. Levine, S., R. Franco-Klaiber, and P. Paradiso. 1987. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:2521-2524.
41. Milich, D., D. Peterson, F. Schodel, J. Jones, and J. Hughes. 1995. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J. Virol. 69:2776-2785.
42. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
43. Murphy, B., B. Graham, G. Prince, E. Walsh, R. Chanock, D. Karzon, and P. Wright. 1986. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J. Clin. Microbiol. 23:1009-1014.
44. Nakajima, H., H. Sano, T. Nishimura, S. Yoshida, and I. Iwamoto. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1145-1154.
45. Olmsted, R., N. Elango, G. Prince, B. Murphy, P. Johnson, B. Moss, R. Chanock, and P. Collins. 1986. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl Acad. Sci. USA 83:7462-7466.
46. Openshaw, P., S. Clarke, and F. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:493-500.
47. Palomo, C., B. Garcia-Barreno, C. Penas, and J. Melero 1991. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J. Gen. Virol. 72:669-675.
48. Pemberton, R., M. Cannon, P. Openshaw, L. Ball, G. Wertz, and B. Askonas. 1987. Cytotoxic T cell specificity for respiratory syncytial virus protiens: fusion protein is an important target antigen. J. Gen Virol. 68:2177-2182.
49. Prince, G., A. Jenson, V. Hemming, B. Murphy, E. Walsh, R. Horswood, and R. Chanock. 1986. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57:721-728.
50. Pulendran, B., G. Kannourakis, S. Nouri, K. Smith, and G. Nossal. 1995. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375:331-334.
51. Rizzo, L. V., R. H. DeKruyff, D. T. Umetsu, and R. R. Caspi. 1995. Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur. J. Immunol. 25:708-716.
52. Roberts, S., D. Lichtenstein, L. Ball, and G. Wertz. 1994. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J. Virol. 68:4538-4546.
53. Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334-348.
54. Shmitz, J., M. Assenmacher, and A. Radbruch. 1993. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur. J. Immunol. 23:191-199.
55. Shanafelt, M., C. Soderberg, A. Allsup, D. Adelman, G. Peltz, and R. Lahesmaa. 1995. Costimulatory signals can selectively modulate cytokine production by subsets of CD4+ T cells. J. Immunol. 154:1684-1690.
56. Shokat, K., and C. Goodnow. 1995. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375:334-338.
57. Simard, C., F. Nadon, C. Seguin, and M. Trudel. 1995. Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection. Antiviral Res. 28:303-315.
58. Srikiatkhachorn, A., and T. Braciale. 1997. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J. Virol. 71:678-685.
59. Stott, E., L. Ball, K. Young, J. Furze, and G. Wertz. 1986. Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J. Virol. 60:607-613.
60. Stott, E., G. Taylor, L. Ball, K. Anderson, K. Young, A. King, and G. Wertz. 1987. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J. Virol. 61:3855-3861.
61. Tang, Y., and B. Graham. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94:1953-1958.
62. Taylor, G., E. Stott, M. Bew, B. Fernie, P. Cote, A. Collins, M. Hughes, and J. Jebbett. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.
63. Wagner, D., P. Muelenaer, F. Henderson, M. Snyder, C. Reimer, E. Walsh, L. Anderson, D. Nelson, and B. Murphy. 1989. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections. J. Clin. Microbiol. 27:589-592.
64. Wagner, D., B. Graham, P. Wright, E. Walsh, H. Kim, C. Reimer, D. Nelson, R. Chanock, and B. Murphy. 1986. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J. Clin. Microbiol. 24:304-306.
65. Walsh, E., C. Hall, M. Brisselli, M. Brandiss, and J. Schlesinger. 1987. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J. Infect. Dis. 155:1198-1204.
66. Walsh E., C. Hall, M. Briselli, M. Brandiss, and J. Schlesinger. 1987. Immunization with glycoprotein subunits of respiratory syncytial virus protect cotton rats against viral infection. J. Infect. Dis. 155:1198-1204.
67. Walsh, E., J. Schlesinger, and M. Brandiss. 1984. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J. Gen. Virol. 65:761-767.
68. Ward, K., P. Lambden, M. Oglivie, and P. J. Watt. 1983. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection J Gen. Virol. 64:1867-1876.
69. Waris, M., C. Tsou, D. Erdman, S. Zaki, and L. Anderson. 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:2852-2860.
70. Wertz, G., P. Collins, Y. Huang, C. Gruber, and S. Levine. 1985. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc. Natl. Acad. Sci. USA 82:4075-4079.